Non-Hodgkin Lymphoma (NHL) Market Overview: 2022-28

Base Year: 2021

Historical Years: 2017-20

Forecast Years: 2022-27

The Non-Hodgkin Lymphoma (NHL) Market is expected to grow at around 7.6% CAGR during the forecast period, i.e., 2022-27. The growth of the market would be driven primarily by the rising prevalence of B-cell lymphoma worldwide and mounting side effects of chemotherapy treatment, which, in turn, is leading to substantial R&D investments in procuring novel drugs to cure NHL. Besides, rapid drug approvals for B-cell lymphoma treatment in both developed & emerging countries and the impressive pipeline of targeted therapies, coupled with the label expansion of currently available therapies for treating various subtypes of NHL, are also driving the market. 

Markntel Advisor’s Non-Hodgkin Lymphoma (NHL) Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Non-Hodgkin Lymphoma (NHL) Market drivers, barriers, Non-Hodgkin Lymphoma (NHL) Market Trends, and Key Players in Non-Hodgkin Lymphoma (NHL) Market.

Download a sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/non-hodgkins-lymphoma-nhl-treatment-market.html

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Non-Hodgkin Lymphoma (NHL) Market Dynamics: 2022-27

Mounting Incidence of B-Cell Lymphoma & Improved Prognosis using Advanced Therapeutics: The growing patient pool for blood cancers, especially B-cell lymphomas, i.e., instigating the need for better clinical & therapeutic patient outcomes in refractory or relapsed cases, is the prime aspect projected to drive the Global Non-Hodgkin Lymphoma (NHL) Market during 2022-27. Moreover, rigorous R&D activities in developing efficient therapeutics for Non-Hodgkin Lymphoma have led to an overall improved prognosis. It, in turn, is driving more individuals toward adopting advanced treatments, which further projects remunerative prospects for the global market over the forecast years.

Browse Full Report with Detail Analysis - https://www.marknteladvisors.com/research-library/non-hodgkins-lymphoma-nhl-treatment-market.html

Non-Hodgkin Lymphoma (NHL) Market (2022-27): Segmentation Outlook

The market report has segmented the market into the following categories:

·       By Diagnosis

o   Biopsy

§  Excisional or Incisional

§  Needle

§  Bone Marrow Aspiration & Biopsy

§  Lumbar Puncture (Spinal Tap)

o   Lab Tests

o   Imaging

§  Chest X-Ray

§  CT Scan

§  MRI

§  PET Scan

§  Ultrasound

o   Blood Tests

·       By Treatment

o   Surgery

o   Stem Cell Transplant

o   Chemotherapy

o   Immunotherapy

§  Monoclonal Antibodies

§  Antibody-drug Conjugates

§  Immunomodulatory Drugs

§  CAR T-cell therapy

o   Targeted Therapy

o   Radiation Therapy

According to report, Among all treatments, monoclonal antibodies (mAbs) of immunotherapy accounted for the largest share in the Global Non-Hodgkin Lymphoma (NHL) Market owing to their outstanding mechanism of action.

·       By End-User

o   Hospitals

o   Specialty Clinics

o   Others (Ambulatory Surgery Centers, etc.)

·       By Region

o   North America

o   South America

o   Europe

o   Middle East & Africa

o   Asia-Pacific

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Non-Hodgkin Lymphoma (NHL) Market:

• AstraZeneca PLC
• AbbVie Inc.
• Baxter International Inc.
• Bayer AG
• Bristol Myers Squibb
• Eli Lilly and Company
• GlaxoSmithKline PLC
• F. Hoffmann-La Roche AG
• Merck & Co., Inc.
• Novartis International AG
• Pfizer Inc.
• Others

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India